Literature DB >> 7525552

c phosphorylation and activation of the IGF-I receptor in src-transformed cells.

J E Peterson1, T Jelinek, M Kaleko, K Siddle, M J Weber.   

Abstract

Using a panel of src mutants partially defective for malignant transformation, our laboratory has previously identified the insulin-like growth factor (IGF-I) receptor as a protein whose tyrosine phosphorylation correlates with transformation by src in embryonic chick cells (Kozma et al., 1990; Kozma and Weber, 1990). It has not been clear, however, whether src-induced phosphorylation altered the enzymatic or signaling properties of the IGF-I receptor and thus whether the IGF-I receptor could be a functionally significant target for pp60v-src. To examine the effect of src expression on the activity of the IGF-I receptor, the human IGF-I receptor was expressed in Rat-1 fibroblasts co-expressing the temperature-sensitive v-src mutant, tsLA29. The IGF-I receptor exhibited an elevated level of tyrosine phosphorylation in src transformed cells even in the absence of IGF-I treatment. Increased receptor phosphorylation occurred rapidly when cells expressing a temperature-conditional src mutant were shifted from the restrictive to the permissive temperature. Src-induced phosphorylation of the receptor was correlated with an increase in the in vitro tyrosine kinase activity of the receptor, both toward itself and exogenous substrates. The src-induced increase in receptor activity was shown to be dependent on tyrosine phosphorylation, as treatment with a tyrosine-specific phosphatase lowered receptor activity. A kinase-defective mutant of the IGF-I receptor also became constitutively phosphorylated in src-transformed cells, ruling out a possible autocrine mechanism for this phosphorylation. Collectively these data indicate that pp60v-src induces ligand-independent phosphorylation and activation of the IGF-I receptor by an intracellular mechanism, consistent with the possibility that receptor phosphorylation could contribute to the genesis of the transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525552

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

Authors:  G Kulik; A Klippel; M J Weber
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 2.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

3.  Ligand-Independent Activation of Platelet-Derived Growth Factor Receptor β during Human Immunodeficiency Virus-Transactivator of Transcription and Cocaine-Mediated Smooth Muscle Hyperplasia.

Authors:  Pranjali N Dalvi; Vijayalaxmi G Gupta; Brooke R Griffin; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

4.  Insulin-like growth factor I receptor signaling in transformation by src oncogenes.

Authors:  B Valentinis; A Morrione; S J Taylor; R Baserga
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.

Authors:  K Hansen; M Johnell; A Siegbahn; C Rorsman; U Engström; C Wernstedt; C H Heldin; L Rönnstrand
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src.

Authors:  G Scholz; C Martinerie; B Perbal; H Hanafusa
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

7.  Tumor promotion by depleting cells of protein kinase C delta.

Authors:  Z Lu; A Hornia; Y W Jiang; Q Zang; S Ohno; D A Foster
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

8.  Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

Authors:  M C Maa; T H Leu; D J McCarley; R C Schatzman; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

9.  Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.

Authors:  Ardeshir Hakam; Quan Fang; Richard Karl; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

10.  The role of SRC family kinases in prostate cancer.

Authors:  Oleg Tatarov; Joanne Edwards
Journal:  Transl Oncogenomics       Date:  2007-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.